Publications included

Pawloski, Pamala A., PharmD, BCOP, FCCP uri icon
Senior Research Investigator


Joined the Institute: 2008

Education and training: PharmD, North Dakota State University; pharmacy practice residency and oncology pharmacy practice residency, University of Kentucky; clinical pharmacology fellowship, University of Texas M.D. Anderson Cancer Center.

Overview/research interests: Optimizing patient outcomes by improving medication management through the application of pharmacogenomics, medication therapy management and medication surveillance.

Current research activities and funding:

Cancer Treatment and Supportive Care Outcomes

  • CRN4: Cancer Research Resources & Collaboration in Integrated Health Care Systems (NCI)
  • Pilot Testing a Biorepository Framework to Enable Genomic Research at HP (HPI)
  • Treatment, Experiences and Barriers among Elderly Colorectal Cancer Patients (PCORI)
  • Implementing Universal Lynch Syndrome Screening across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizational Contexts (NCI)

Medication Safety and Adverse Event Surveillance

  • Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP) Maintenance (FDA)
  • Evaluation of the Risk of Neural Tube Defects Among Live Births Exposed to Maternal Prescription Opioids During Early Pregnancy (FDA)
  • FDA Sentinel Initiative (FDA)
  • Innovation in Medical Evidence and Development Surveillance (IMEDS) Signal Refinement and Signal Characterization Bundles (public-private
  • Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) Comparative Effectiveness of Biosimilars (public-private)



selected publications